Related references
Note: Only part of the references are listed.Expression of PD-1, PD-L1, and PD-L2 in posttransplant lymphoproliferative disorder after solid organ transplantation
Amelie Kinch et al.
LEUKEMIA & LYMPHOMA (2019)
Clinicopathological evaluation of the programmed cell death 1 (PD1)/programmed cell death-ligand 1 (PD-L1) axis in post-transplant lymphoproliferative disorders: association with Epstein-Barr virus, PD-L1 copy number alterations, and outcome
Luis Veloza et al.
HISTOPATHOLOGY (2019)
Epstein Barr Virus Associated B-Cell Lymphomas and Iatrogenic Lymphoproliferative Disorders
Jennifer L. Crombie et al.
FRONTIERS IN ONCOLOGY (2019)
Dual blockade of the PI3K/Akt/mTOR pathway inhibits posttransplant Epstein-Barr virus B cell lymphomas and promotes allograft survival
Adam X. Sang et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2019)
The Tumor Microenvironment in Post-Transplant Lymphoproliferative Disorders
Lukas Marcelis et al.
CANCER MICROENVIRONMENT (2019)
Bortezomib promotes KHSV and EBV lytic cycle by activating JNK and autophagy
Marisa Granato et al.
SCIENTIFIC REPORTS (2017)
Mutational landscape of B-cell post-transplant lymphoproliferative disorders
Thomas Menter et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
EBV-Positive and EBV-Negative Posttransplant Diffuse Large B Cell Lymphomas Have Distinct Genomic and Transcriptomic Features
J. Finalet Ferreiro et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
T cells for viral infections after allogeneic hematopoietic stem cell transplant
Catherine M. Bollard et al.
BLOOD (2016)
Lenalidomide, Thalidomide, and Pomalidomide Reactivate the Epstein-Barr Virus Lytic Cycle through Phosphoinositide 3-Kinase Signaling and Ikaros Expression
Richard J. Jones et al.
CLINICAL CANCER RESEARCH (2016)
Rituximab-based treatments followed by adoptive cellular immunotherapy for biopsy-proven EBV-associated post-transplant lymphoproliferative disease in recipients of allogeneic hematopoietic stem cell transplantation
Xinmiao Jiang et al.
ONCOIMMUNOLOGY (2016)
Epstein-Barr Virus Modulates Host Cell MicroRNA-194 to Promote IL-10 Production and B Lymphoma Cell Survival
A. Harris-Arnold et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2015)
The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder
M. R. Luskin et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2015)
How I treat posttransplant lymphoproliferative disorders
Daan Dierickx et al.
BLOOD (2015)
Immune checkpoint blockade in hematologic malignancies
Philippe Armand
BLOOD (2015)
Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study
Peter Vandenberghe et al.
LANCET HAEMATOLOGY (2015)
A Comprehensive Analysis of the Cellular and EBV-Specific MicroRNAome in Primary CNS PTLD Identifies Different Patterns Among EBV-Associated Tumors
S. E. K. Fink et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2014)
The Molecular Balancing Act of p16INK4a in Cancer and Aging
Kyle M. LaPak et al.
MOLECULAR CANCER RESEARCH (2014)
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1
Leila Rouhigharabaei et al.
PLOS ONE (2014)
Gene Expression Profiling Reveals Clear Differences Between EBV-Positive and EBV-Negative Posttransplant Lymphoproliferative Disorders
J. Morscio et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Molecular Pathogenesis of B-Cell Posttransplant Lymphoproliferative Disorder: What Do We Know So Far?
J. Morscio et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)
PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies
Benjamin J. Chen et al.
CLINICAL CANCER RESEARCH (2013)
Constitutive AP-1 Activity and EBV Infection Induce PD-L1 in Hodgkin Lymphomas and Posttransplant Lymphoproliferative Disorders: Implications for Targeted Therapy
Michael R. Green et al.
CLINICAL CANCER RESEARCH (2012)
Post Transplant Lymphoproliferative Disorders: Risk, Classification, and Therapeutic Recommendations
Deepa Jagadeesh et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2012)
Analysis of Epstein-Barr Virus-Regulated Host Gene Expression Changes through Primary B-Cell Outgrowth Reveals Delayed Kinetics of Latent Membrane Protein 1-Mediated NF-κB Activation
Alexander M. Price et al.
JOURNAL OF VIROLOGY (2012)
Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial
Ralf Trappe et al.
LANCET ONCOLOGY (2012)
Reduction of Immunosuppression as Initial Therapy for Posttransplantation Lymphoproliferative Disorder
R. Reshef et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Association of HLA Polymorphisms with Post-transplant Lymphoproliferative Disorder in Solid-Organ Transplant Recipients
R. Reshef et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorders: Pathogenetic Insights for Targeted Therapy
J. P. Nourse et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
JAK2 rearrangements, including the novel SEC31A-JAK2 fusion, are recurrent in classical Hodgkin lymphoma
Katrien Van Roosbroeck et al.
BLOOD (2011)
IL-6 and IL-10 in post-transplant lymphoproliferative disorders development and maintenance: a longitudinal study of cytokine plasma levels and T-cell subsets in 38 patients undergoing treatment
Carl Hinrichs et al.
TRANSPLANT INTERNATIONAL (2011)
Racial Variation in the Development of Posttransplant Lymphoproliferative Disorders After Renal Transplantation
Robert Nee et al.
TRANSPLANTATION (2011)
Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
Helen E. Heslop et al.
BLOOD (2010)
Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma
Michael R. Green et al.
BLOOD (2010)
Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome
Christian Steidl et al.
BLOOD (2010)
Single nucleotide polymorphism-arrays provide new insights in the pathogenesis of post-transplant diffuse large B-cell lymphoma
Andrea Rinaldi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Synthesis and Early Development of Hexadecyloxypropyl-cidofovir: An Oral Antipoxvirus Nucleoside Phosphonate
Karl Y. Hostetler
VIRUSES-BASEL (2010)
Posttransplant Lymphoproliferative Disease in Liver Transplant Patients
Christina Hartmann et al.
Current Infectious Disease Reports (2010)
Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation
Ola Landgren et al.
BLOOD (2009)
Incidence of PTLD in pediatric renal transplant recipients receiving basiliximab, calcineurin inhibitor, sirolimus and steroids
R. A. McDonald et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
PD-1 and its ligands in tolerance and immunity
Mary E. Keir et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
Gene expression profiling of Epstein-Barr virus-positive and -negative monomorphic B-cell posttransplant lymphoproliferative disorders
Fiona E. Craig et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2007)
FOXP1: a potential therapeutic target in cancer
Henry B. Koon et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies
Susan R. Perrine et al.
BLOOD (2007)
The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection
Arlene H. Sharpe et al.
NATURE IMMUNOLOGY (2007)
Comparative genome-wide profiling of post-transplant lymphoproliferative disorders and diffuse large B-cell lymphomas
Andrea Rinaldi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression
S Caillard et al.
TRANSPLANTATION (2005)
FOXP1, a gene highly expressed in a subset of diffuse large B-cell lymphoma, is recurrently targeted by genomic aberrations
I Wlodarska et al.
LEUKEMIA (2005)
Characteristic pattern of chromosomal imbalances in posttransplantation lymphoproliferative disorders:: Correlation with histopathological subcategories and EBV status
HA Poirel et al.
TRANSPLANTATION (2005)
Post-transplant lymphoproliferative disorders: molecular basis of disease histogenesis and pathogenesis
D Capello et al.
HEMATOLOGICAL ONCOLOGY (2005)
Epstein-Barr viral load, interleukin-6 and interleukin-10 levels in post-transplant lymphoproliferative disease: A nested case-control study in a renal transplant cohort
OCG Baiocchi et al.
LEUKEMIA & LYMPHOMA (2005)
Lymphomas after solid organ transplantation:: A collaborative transplant study report
G Opelz et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome
SL Barrans et al.
BLOOD (2004)
Molecular histogenesis of posttransplantation lymphoproliferative disorders
D Capello et al.
BLOOD (2003)
Epstein-Barr virus (EBV) load and interleukin-10 in EBV-positive and EBV-negative post-transplant lymphoproliferative disorders
G Muti et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Expansion in scid mice of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease biopsy material
I Johannessen et al.
JOURNAL OF GENERAL VIROLOGY (2002)
Post renal transplantation human herpesvirus 8-associated lymphoproliferative disorder and Kaposi's sarcoma
J Kapelushnik et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Risk factors for posttransplant lymphoproliferative disorder (PTLD) in pediatric kidney transplantation: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)
VR Dharnidharka et al.
TRANSPLANTATION (2001)
Share Paper
